Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 1,466 | 3,458 | 10,567 | 2,389 | 821 |
| Gross Profit | 1,466 | 3,458 | 10,567 | 2,389 | 821 |
| Operating Expenses | 13,085 | 10,844 | 16,901 | 9,314 | 12,963 |
| Operating Income | -11,619 | -7,386 | -6,334 | -6,925 | -12,142 |
| Interest Expense | 1,225 | 1,242 | 1,242 | 1,191 | 1,165 |
| Other Income | -1,805 | -1,509 | 2,147 | 115 | 1,135 |
| Pre-tax Income | -14,649 | -10,137 | -5,429 | -8,001 | -12,172 |
| Net Income Continuous | -14,649 | -10,137 | -5,429 | -8,001 | -12,172 |
| Net Income | $-14,649 | $-10,137 | $-5,429 | $-8,001 | $-12,172 |
| EPS Basic Total Ops | -0.23 | -0.17 | -0.09 | -0.14 | -0.23 |
| EPS Basic Continuous Ops | -0.23 | -0.17 | -0.09 | -0.14 | -0.23 |
| EPS Diluted Total Ops | -0.23 | -0.17 | -0.09 | -0.14 | -0.23 |
| EPS Diluted Continuous Ops | -0.23 | -0.17 | -0.09 | -0.14 | -0.23 |
| EBITDA(a) | $-11,465 | $-7,223 | $-6,167 | $-6,752 | $-11,946 |